Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Anandamide
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Mechoulam R | The promise of advances in the field of endocannabinoids. | 2004 Feb-Apr | Neuro Endocrinol. Lett. | pmid:15159675 |
Fride E | The endocannabinoid-CB receptor system: Importance for development and in pediatric disease. | 2004 Feb-Apr | Neuro Endocrinol. Lett. | pmid:15159678 |
Russo EB | Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? | 2004 Feb-Apr | Neuro Endocrinol. Lett. | pmid:15159679 |
Chen P et al. | Metabolism of anandamide in cerebral microvascular endothelial cells. | 2004 | Prostaglandins Other Lipid Mediat. | pmid:15165032 |
Breivogel CS et al. | Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids. | 2004 | Neuropharmacology | pmid:15165836 |
Alger BE | Endocannabinoids: getting the message across. | 2004 | Proc. Natl. Acad. Sci. U.S.A. | pmid:15173576 |
Kim J and Alger BE | Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. | 2004 | Nat. Neurosci. | pmid:15184902 |
Witting A et al. | Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice. | 2004 | J. Neurochem. | pmid:15189359 |
Peroni RN et al. | Sex-linked differences in the vasorelaxant effects of anandamide in vascular mesenteric beds: role of oestrogens. | 2004 | Eur. J. Pharmacol. | pmid:15189776 |
MartÃnez-González D et al. | Oleamide and anandamide effects on food intake and sexual behavior of rats. | 2004 | Neurosci. Lett. | pmid:15193744 |
Kraft B et al. | Cannabinoid receptor-independent suppression of the superoxide generation of human neutrophils (PMN) by CP55 940, but not by anandamide. | 2004 | Life Sci. | pmid:15193957 |
Ortega-Gutiérrez S et al. | Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake. | 2004 | Biochemistry | pmid:15209515 |
Li J et al. | Muscle pressor reflex: potential role of vanilloid type 1 receptor and acid-sensing ion channel. | 2004 | J. Appl. Physiol. | pmid:15220301 |
Lichtman AH et al. | Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. | 2004 | J. Pharmacol. Exp. Ther. | pmid:15229230 |
Barros DM et al. | Interactions between anandamide-induced anterograde amnesia and post-training memory modulatory systems. | 2004 | Brain Res. | pmid:15234253 |
D'Amico M et al. | Inhibition by anandamide and synthetic cannabimimetics of the release of [3H]D-aspartate and [3H]GABA from synaptosomes isolated from the rat hippocampus. | 2004 | Neurochem. Res. | pmid:15260134 |
Boldrup L et al. | A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase. | 2004 | J. Biochem. Biophys. Methods | pmid:15262451 |
Yue HY et al. | AM404 enhances the spontaneous release of L-glutamate in a manner sensitive to capsazepine in adult rat substantia gelatinosa neurones. | 2004 | Brain Res. | pmid:15276889 |
Akerman S et al. | Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. | 2004 | Br. J. Pharmacol. | pmid:15277315 |
Scorticati C et al. | The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen. | 2004 | Proc. Natl. Acad. Sci. U.S.A. | pmid:15280536 |
Rockwell CE and Kaminski NE | A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes. | 2004 | J. Pharmacol. Exp. Ther. | pmid:15284281 |
Kelley BG and Thayer SA | Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors. | 2004 | Eur. J. Pharmacol. | pmid:15288572 |
De Petrocellis L et al. | Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels. | 2004 | Br. J. Pharmacol. | pmid:15289293 |
McFarland MJ et al. | A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide. | 2004 | J. Biol. Chem. | pmid:15292270 |
Lazzarin N et al. | Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle. | 2004 | Gynecol. Endocrinol. | pmid:15293893 |
Do Y et al. | Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. | 2004 | J. Immunol. | pmid:15294950 |
Wiley JL et al. | A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats. | 2004 | Exp Clin Psychopharmacol | pmid:15301634 |
Blázquez C et al. | Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. | 2004 | Cancer Res. | pmid:15313899 |
Oka S et al. | 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. | 2004 | J. Leukoc. Biol. | pmid:15316028 |
McAllister SD et al. | Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation. | 2004 | J. Biol. Chem. | pmid:15326174 |
Di Marzo V et al. | The anandamide membrane transporter. Structure-activity relationships of anandamide and oleoylethanolamine analogs with phenyl rings in the polar head group region. | 2004 | Bioorg. Med. Chem. | pmid:15351399 |
Giuffrida A et al. | Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. | 2004 | Neuropsychopharmacology | pmid:15354183 |
Appendino G et al. | Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential. | 2005 | J. Pharmacol. Exp. Ther. | pmid:15356216 |
Movsesyan VA et al. | Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways. | 2004 | Cell Death Differ. | pmid:15375383 |
RodrÃguez de Fonseca F | [The endocannabinoid system and food intake control]. | 2004 Apr-Jun | Rev Med Univ Navarra | pmid:15382609 |
Bátkai S et al. | Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. | 2004 | Circulation | pmid:15451779 |
Contassot E et al. | Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1. | 2004 | J. Neuropathol. Exp. Neurol. | pmid:15453094 |
Huitron-Resendiz S et al. | Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase. | 2004 | Sleep | pmid:15453543 |
Piomelli D | The endogenous cannabinoid system and the treatment of marijuana dependence. | 2004 | Neuropharmacology | pmid:15464150 |
Fernández-Rodriguez CM et al. | Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis. | 2004 | Liver Int. | pmid:15482346 |
Ghafouri N et al. | Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. | 2004 | Br. J. Pharmacol. | pmid:15492019 |
Lanzafame AA et al. | Effects of anandamide on the binding and signaling properties of M1 muscarinic acetylcholine receptors. | 2004 | Biochem. Pharmacol. | pmid:15498511 |
McFarland MJ and Barker EL | Anandamide transport. | 2004 | Pharmacol. Ther. | pmid:15518883 |
Triggle CR et al. | The endothelium in health and disease: a discussion of the contribution of non-nitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes. | 2004 | Mol. Cell. Biochem. | pmid:15524164 |
Holt S et al. | Lipopolysaccharide-induced pulmonary inflammation is not accompanied by a release of anandamide into the lavage fluid or a down-regulation of the activity of fatty acid amide hydrolase. | 2004 | Life Sci. | pmid:15530507 |
Habayeb OM et al. | Plasma levels of the endocannabinoid anandamide in women--a potential role in pregnancy maintenance and labor? | 2004 | J. Clin. Endocrinol. Metab. | pmid:15531501 |
Muthian S et al. | Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. | 2004 | Neuroscience | pmid:15541895 |
Golech SA et al. | Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. | 2004 | Brain Res. Mol. Brain Res. | pmid:15548432 |
Basavarajappa BS and Hungund BL | Role of the endocannabinoid system in the development of tolerance to alcohol. | 2005 Jan-Feb | Alcohol Alcohol. | pmid:15550443 |
RodrÃguez de Fonseca F et al. | The endocannabinoid system: physiology and pharmacology. | 2005 Jan-Feb | Alcohol Alcohol. | pmid:15550444 |